Login · Register

Holiday Notification: Cayman Chemical will be closed Monday, September 6, 2010, in observance of the Labor Day holiday. More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, September 7, 2010. Thank you for your patience.

Research Area · Hypertension

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords
10007975 (±)11,12-DHET-d11 Exclusive - ≥99% deuterated product ✓ 2008-03-17 30.395856353591 -11-12-dhet-d11 (±)11,12-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)11,12-DiHETrEs deuterated epoxide hydrolase deuterated deuterium
10006413 (±)11(12)-EET-d11 Exclusive - ≥99% deuterated product ✓ 2008-03-25 41.125064456722 -11-12-eet-d11 (±)11(12)-EpETrE-d11 epoxides epoxygenases 11,12-EETs cytochrome P450 (+/-)11,12-EpETrEs (+/-)11(12)-EpETrEs deuterated deuterium
10004549 11β-Hydroxysteroid Dehydrogenase (Type 2) Polyclonal Antibody - 2005-10-05 9.806104972376 11-hydroxysteroid-dehydrogenase-type-2-polyclonal-antibody Corticosteroid 11β-Dehydrogenase Isozyme 2; 11β-HSD2 proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry corticosteroids regulations sodium homeostasis pathophysiology hypertension converts converting cortisol inactive cortisone mutations genes encoding induction hypertension hypokalemia syndromes mineralcorticoid excess mRNA expressed placenta target tissues kidneys mouse murine tissue-specific developmentally regulated glucocorticoid-medicated maturation 11b-HSD 11beta-HSD 11.beta.-HSD 11b HSD 11b-hydroxysteroid 11beta-hydroxysteroid endocrinology immunoblotting
10008040 (±)14,15-DHET-d11 - ≥99% deuterated product 2008-03-18 64.776519337017 -14-15-dhet-d11 (±)14,15-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)14,15-DiHETrEs deuterated epoxide hydrolase deuterium
10004946 14,15-EE-5(Z)-E Exclusive 519038-92-7 >98% ✓ 2007-01-15 70.353480662983 14-15-ee-5-z-e 14,15-Epoxyeicosa-5(Z)-enoic Acid 14,15-EpETrE 14,15-EETs antagonists hypertension vasodilation vasodilator vasoconstriction vasoconstrictor EDHT endothelium-derived hyperpolarizing factor U46619 bovine arteries endocrinology EEZE
10010486 14,15-EE-8(Z)-E Exclusive 519038-93-8 ≥98% ✓ 2008-11-03 23.675408839779 14-15-ee-8-z-e 14,15-Epoxyeicosa-8(Z)-enoic Acid 14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE
10009286 (±)14(15)-EET-SI 218461-97-3 >95% 2007-05-14 37.276187845304 -14-15-eet-si (±)14(15)-EET-sulfonimide; (±)14(15)-EpETrE-SI arachidonic acid AA endothelium epoxytrienoic acid EETs EpETrEs cytochromes P450 acetylcholine bradykinin sulfonamide analog tyrosine phosphorylation mitogenesis renal epithelial cells hypertension EDHF
10010635 (±)16-HETE - ≥98% 2008-06-09 18.474401473297 -16-hete CYP450 eicosanoid metabolism kidneys ATPase ion transport vasodilation renal hypertension
10004385 16(R)-HETE 183509-22-0 >98% 2008-07-28 1.724723756906 16-r-hete CYP450 eicosanoid metabolism kidney ion transport vasodilation renal hypertension HETEs
13076 16(R)-Iloprost - ≥98% 2008-10-10 24.321151012891 16-r-iloprost prostacyclin platelet aggregation IP receptors EP vasodilation pulmonary hypertension stereoisomers inhibits inhibitors inhibition iloprosts PGI2
10004384 16(S)-HETE 183509-23-1 ≥98% 2008-07-23 1.507182320442 16-s-hete inhibitors inhibits inhibitions CYP450 eicosanoid metabolism kidneys ATPase ion transport renal hypertension HETEs 16SHETE 16S-HETE 16 S HETE
13077 16(S)-Iloprost 74843-14-4 ≥98% 2008-10-10 24.321151012891 16-s-iloprost prostacyclin platelet aggregation IP receptors EP vasodilation pulmonary hypertension stereoisomers iloprosts inhibits inhibitors inhibition PGI2
10011305 17(S)-HETE 183509-25-3 >98% 2008-08-25 7.726440410418 17-s-hete CYP450 Eicosanoid metabolism kidney ATPase ion transport renal hypertension
10010638 (±)18-HETE Exclusive - ≥97% ✓ 2008-06-13 2.100298342542 -18-hete CYP450 eicosanoid metabolism kidney vasodilation CYP2E1 20-HETE 20HETE 18HETE renal hypertension
10007767 19(R)-HETE 115461-39-7 >98% 2008-05-27 4.083977900552 19-r-hete hypertension arterioles CYP450 kidneys angiotensin II vasodilator vasoconstricition 20-HETE 19HETE 19-HETE renal 19 HETE
10007766 19(S)-HETE Exclusive New 115461-40-0 ≥98% ✓ 2010-04-06 2.041988950276 19-s-hete cytochromes P450 CYP450 metabolites arachidonic acids kidneys angiotensin II CYP2E1 vasodilators renal preglomerular vessels ATPase hypertension arterioles vasoconstriction
10007912 20-carboxy Arachidonic Acid Exclusive 79551-84-1 >98% ✓ 2007-08-15 40.377605893186 20-carboxy-arachidonic-acid 20-COOH-AA 20-HETE metabolites PPAR.alpha. PPAR.gamma. vasorelaxation activators CYP4F3B hypertension cytochrome P450 CYP450 perioxisome proliferator activated receptor PPARs PPARalpha PPARgamma
10008596 (±)5(6)-EET Ethanolamide Exclusive - >95% ✓ 2006-10-20 11.558705603788 -5-6-eet-ethanolamide (±)5(6)-EpETrE Ethanolamide epoxides epoxygenases 5,6-EETs cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs fatty acids esters ethanolamides metabolites AEA anandamides arachidonoyl neurotransmitters cannabinergic endocannabinoids CB1 CB2 receptors central peripheral FAAH hydrolases metabolism lipoxygenases inhibition (±)5(6)-Epoxy eicosatrienoyl 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide
13260 6-keto Prostaglandin E1 67786-53-2 >99% 67.502872928176 6-keto-prostaglandin-e1 6-keto PGE1 6-keto-PGE1 metabolites prostaglandins
10007210 6-keto Prostaglandin E1 Lipid Maps MS Standard 67786-53-2 >99% 2008-11-03 44.861528545119 6-keto-prostaglandin-e1-lipid-maps-ms-standard 6-keto PGE1 6-keto-PGE1 metabolites prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS
10009998 (±)8,9-DHET-d11 Exclusive - ≥99% deuterated product ✓ 2008-03-17 9.351325966851 -8-9-dhet-d11 epoxides epoxygenases DHT hydrolases (+/-)14,15-DiHETrEs deuterated epoxide hydrolase deuterated deuterium
18112 8,9-EE-14(Z)-E Exclusive - ≥95% ✓ 2009-03-15 6.380018416206 8-9-ee-14-z-e 8,9-Epoxyeicosa-14(Z)-enoic Acid 14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE
10009532 (±)8(9)-EET-d11 Exclusive - ≥99% deuterated product ✓ 2008-03-25 9.058563535911 -8-9-eet-d11 (±)8(9)-EpETrE-d11 epoxides epoxygenases cytochrome P450 (±)8,9-EpETrEs (+/-)8,9-EpETrEs fatty acids (+/-)8(9)EpETrEs 8(9)EETs eicosatrienoic 8,9-EETs deuterated racemic mixture
10008597 (±)8(9)-EET Ethanolamide - >98% 2007-07-05 15.586008287292 -8-9-eet-ethanolamide (±)8(9)-EpETrE Ethanolamide AEA endocannabinoids arachidonoyl ethanolamide CYP450 cytochrome P450 metabolism ethanolamides hypertension
589451 AcSDKP EIA Kit - 183.304475138121 acsdkp-eia-kit N-Acetyl Ser-Asp-Lys-Pro EIA Kit; AcSDKP ELISA Kit N-Acetyl-Seryl-Aspartyl-Lysyl-Proline serine aspartamine lysine measures kits eias enzyme immunoassays ELISAs growth regulatory hormones plasma urine spi-bio spibio A05881 atherosclerosis hypertension endocrinology assays
10004377 Aldosterone EIA Kit - Monoclonal - 2004-04-21 331.428402394107 aldosterone-eia-kit-monoclonal Aldosterone ELISA Kit - Monoclonal 582041 steroids hormones mineralocorticoids salt reabsorption electrolytes renin-angiotensin system RAS enzyme immunoassays eias elisas measures kits hypertension endocrinology assays
13648 Alfuzosin (hydrochloride) New 81403-68-1 ≥98% 2010-07-19 0E-12 alfuzosin-hydrochloride Uroxatral; SL 77-499-10 α1-adrenergic receptors antagonists lower urinary tract symptoms benign prostatic hyperplasia BPH adrenoceptors α1A α1B α1D contractions smooth muscles antihypertensives vasodilators urinary flow 133880-44-1 Urion Alfoten SL 77499-10 anti-hypertensives alpha 1 .alpha.1
10010663 Amlodipine-d4 (besylate) - ≥99% deuterated product 2009-08-10 0E-12 amlodipine-d4-besylate deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry dihydropyridine pyridines calcium channel blocker angina pectoris hypertension 88150-42-9
589301 Angiotensin II EIA Kit - 141.064143646408 angiotensin-ii-eia-kit Angiotensin II ELISA Kit hypertension angiotensin measures kits eias enzyme immunoassays ELISAs spi-bio spibio A05880 atherosclerosis endocrinology assays
13523 Apelin-13 New 217082-58-1 ≥95% 2010-06-29 0E-12 apelin-13 ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids
583951 Arginine Vasopressin EIA Kit - 2007-07-19 150.981843294826 arginine-vasopressin-eia-kit Vasopressin EIA Kit; AVP ELISA Kit; Antidiuretic Hormone (ADH) EIA Kit; Argipressin EIA Kit enzymes immunoassays measurements arg8 measures kits eias ELISAs AChE acetylcholinesterases plasmas serums argipressin antidiuretic hormones ADH amino acids peptides regulates regulation renal water excretion cardiovascular mammals epithelial cells urinary tracts urine blood stimulates stimulation constriction capillaries aterioles pressure depressions congestive hearts failures anxious-retarded argipressins APH antidiuretics endocrinology assays
10009345 Arginine Vasopressin EIA Kit (Solid Plate) - 2007-07-19 117.903943699026 arginine-vasopressin-eia-kit-solid-plate Vasopressin EIA Kit (Solid Plate); Argipressin EIA Kit (Solid Plate); Antidiuretic Hormone (ADH) EIA Kit (Solid Plate); AVP ELISA Kit (Solid Plate) AVP eias enzymes immunoassays kits measures measurements ELISAs
589401 Atriopeptin (rat) EIA Kit - 24.620883977900 atriopeptin-rat-eia-kit Atriopeptin (rat) ELISA Kit naturiuretic auriculin measures kits eias enzyme immunoassays ELISAs atherosclerosis pi-bio spibio A05103 hypertension endocrinology assays
10007927 AUDA Exclusive 479413-70-2 >98% ✓ 2006-04-28 47.803832872928 auda epoxides hydrolases hypertension dihydroxy-eicosatrienoic acids DHETs 11(12)-EETs 14(15)-EETs blood pressure soluble sEH inhibits inhibitors inhibition peroxisome proliferator-activated receptors PPARalpha PPAR.alpha. DiHETrEs EpETrEs endocrinology
10005186 CAY10441 Exclusive 221529-58-4 >98% ✓ 2004-09-16 112.584337016574 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis
10005913 CAY10449 Exclusive - >98% ✓ 2004-10-26 202.691795580110 cay10449 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449
10012447 CG 4305 New - ≥95% 2010-05-12 0E-12 cg-4305 antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory
30001 cGMP Alprostadil New GMP API 745-65-3 2010-08-17 0E-12 cgmp-alprostadil Prostaglandin E1
30024 cGMP Alprostadil-Alfadex New GMP API 93591-00-5 2010-08-17 0E-12 cgmp-alprostadil-alfadex Prostaglandin E1 with α-cyclodextrin
30010 cGMP Epoprostenol (sodium salt) New GMP API 61849-14-7 2010-08-17 0E-12 cgmp-epoprostenol-sodium-salt Prostaglandin I2 (sodium salt); Prostacyclin (sodium salt)
589101 CGRP (human) EIA Kit - 171.001381215470 cgrp-human-eia-kit Calcitonin Gene-related Peptide (human) EIA Kit; CGRP (human) ELISA Kit calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neurochemistry neuroscience spibio A05481 endocrinology assays
10007923 CUDA Exclusive 479413-68-8 >98% ✓ 2006-04-28 42.116700868192 cuda epoxides hydrolases hypertension dihydroxy eicosatrienoic acids DiHETrEs DHETs 11(12)-EETs 14(15)-EETs EpETrEs blood pressure soluble sEH inhibits inhibitors inhibition peroxisome proliferator-activated receptors PPARalpha PPAR.alpha. activates activation endocrinology
10018 DDMS 206052-03-1 >98% 2005-02-22 5.549723756906 ddms Dibromo-dodecenyl-methylsulfimide 20-HETEs inhibits inhibitors inhibition synthesis CYP450-4A2 renal hypotension vascular homeostasis circulation kidneys vasodilation vasodilators NONOates CYP4A2 donors cytochrome
10010588 Desmethylsildenafil-d8 Citrate - >98% deuterated product 2008-04-14 0E-12 desmethylsildenafil-d8-citrate drugs PAH pulmonary arterial hypertension erectile dysfunction impotence
10006865 Docosahexaenoic Acid methyl ester 2566-90-7 >98% 2005-09-06 33.374751381215 docosahexaenoic-acid-methyl-ester Cervonic Acid methyl ester; DHA methyl ester polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 esters diets dietary supplements hypertension neonatal photoreceptor degeneration retinitis pigmentosa depiration neural tissues retina
10008610 Epoxy Fluor 7 863223-43-2 >98% 2006-08-30 21.267289364641 epoxy-fluor-7 epoxides hydrolases fluorescence enzymes activity inhibition screening hypertension inflammation sepsis EETs DHETs EpETrEs DiHETrEs fluorescent SEH soluble endocrinology
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 30.874281767956 ha-1077-hydrochloride Eril; Fasudil (hydrochloride) protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers
10011038 Hemopressin - 2009-08-13 58.529090909091 hemopressin peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive
10005518 IP Receptor (human) Polyclonal Antibody - 2004-10-21 21.225132305903 ip-receptor-human-polyclonal-antibody Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis
10010572 Lercanidipine-d3 (hydrochloride) - >99% deuterated product 2008-04-14 0E-12 lercanidipine-d3-hydrochloride SPI blocker calcium dihydropyrine neurochemistry
16833 Lisinopril 76547-98-3 ≥98% 2009-03-09 2.077348066299 lisinopril MK 522; MK 521 inhibitors inhibits inhibition angiotensin I II ACE endothelin 1 nitric oxide renin hypertension diabetes
10010971 Luminex® 11-dehydro Thromboxane B2 Kit - 2008-01-24 52.225662983425 luminex-11-dehydro-thromboxane-b2-kit Luminex® 11-dehydro TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays
10009835 MK 0524 571170-77-9 >98% 2008-05-06 62.451239147592 mk-0524 Laropiprant antagonist PGD2 allergy asthma DP1 niacin vasodilations flushing dyslipidemia receptors atherosclerosis hypertension inflammation mk0524
10010412 MRE-269 Exclusive 475085-57-5 ≥98% ✓ 2008-11-06 64.450011049724 mre-269 MRE269 prostaglandins PGI2 IP receptors inflammation NS-304 NS304 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs prodrugs
10010653 Nisoldipine-d3 - ≥99% deuterated product 2009-04-15 0E-12 nisoldipine-d3 63675-72-9 86189-67-5 calcium channel dihydropyridine cardiac failure angina deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry
10010411 NS-304 475086-01-2 >98% 2008-04-09 56.267127071823 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs
10006803 O-1602 317321-41-8 >98% 2005-09-12 17.105911602209 o-1602 abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant
10006804 O-1821 35482-50-9 >97% 2005-09-12 0.884493554327 o-1821 abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation
10004914 O-1918 536697-79-7 >98% 2005-09-09 3.982550644567 o-1918 antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918
600240 Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence) New - 2010-03-31 0E-12 orexin-1-receptor-step-reporter-assay-kit-luminescence OX1R hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists
600250 Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence) New - 2010-03-31 0E-12 orexin-2-receptor-step-reporter-assay-kit-luminescence OX2R hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists
70515 Ozagrel 82571-53-7 >98% 3.896095764272 ozagrel OKY-046 thromboxanes synthases inhibitors inhibits imidizoles TXAs antihypertensive inhibition atherosclerosis
10007852 Pargyline (hydrochloride) 306-07-0 >98% 2006-08-30 48.184551104972 pargyline-hydrochloride MAO inhibitors inhibits inhibition ROS-mediated Hypertension 3 blood pressures systolic brains monocytes hypertrophy reactive oxygen species endocrinology
10009567 PCSK9 Western Ready Control - 2007-01-31 10.271860036832 pcsk9-western-ready-control Proprotein Convertase Subtilisin Kexin 9; NARC-1 PSEC0052 subtilisin serine proteases LDLs low density lipoproteins cholesterol receptors golgi atherosclerosis
10009134 PHOME Exclusive - >98% ✓ 2007-01-16 43.239459791283 phome sEH epoxides hydrolase inhibitors inhibition inhibits substrates HTS fluorogenic high throughput screening fluorescent fluorescence hypertension endocrinology
10011724 Propenyl-L-NIO (hydrochloride) Exclusive - >90% ✓ 2008-08-19 9.454972375691 propenyl-l-nio-hydrochloride ENIPO nitric oxide synthase NOS iNOS selective inhibitors inhibits inhibition
10007599 Prorenin (human recombinant) - >99% by SDS-PAGE 2005-10-19 83.509309392265 prorenin-human-recombinant enzymes aspartyl proteases angiotensins II glycoproteins angiotensinogen salt balance hypertension angiotensinogens kidney renal preprorenin endocrinology
10010 Prostaglandin A1 14152-28-4 >98% 111.669352801894 prostaglandin-a1 PGA1 prostaglandins renal vasodilation pge1 dehydration semen antimitotic antiproliferative
10020 Prostaglandin A1 ethyl ester 93464-24-5 >98% 101.926077348067 prostaglandin-a1-ethyl-ester PGA1 ethyl ester PGA1 renal vasodilation prostaglandins esters prodrugs lipid-soluble
12990 Prostaglandin D3 71902-47-1 >98% 97.405607734806 prostaglandin-d3 PGD3 PGD3 omega-3 w-3 .omega.-3 metabolites EPA eicoaspentaenoic acid prostaglandins
13010 Prostaglandin E1 745-65-3 >98% 69.748572259377 prostaglandin-e1 Alprostadil; PGE1 PGE1 vasodilation atherosclerosis erectile dysfunction prostaglandins pharma:1
13010.1 Prostaglandin E1 Analytical Reference Standard 745-65-3 >99% 27.062348066298 prostaglandin-e1-analytical-reference-standard Alprostadil; PGE1 PGE1 vasodilation USP erectile dysfunction prostaglandins
10006906 Renin Fluorogenic Substrate - >95% 2006-12-12 108.399092344120 renin-fluorogenic-substrate substrates aspartyl proteases angiotensinogens peptides peptide-EDANS non-fluorescent quenching molecules Dabcyl fluorescent excitation emission hypertension endocrinology
10006217 Renin (human recombinant) - >99% by SDS-PAGE 2004-12-13 75.871298342541 renin-human-recombinant enzymes aspartyl proteases angiotensins II glycoproteins angiotensinogen salt balance hypertension angiotensinogens kidney renal preprorenin atherosclerosis endocrinology
10006270 Renin Inhibitor Screening Assay Kit - 2005-05-04 64.085943172849 renin-inhibitor-screening-assay-kit Protease measurement assays aspartyl renal juxtaglomerular cells sodium depletion blood volume pressure .beta.-adrenergic stimulation angiotensinogens angiotensins I II converting ACE monomeric zinc metalloenzymes vascular endothelium messengers RAS vasoconstrictor peripheral hypertension receptors blockers fluorescence fluorescent fluorometric atherosclerosis endocrinology
13082 Resorcinolnaphthalein 41307-63-5 ≥98% 2009-02-24 66.719907918969 resorcinolnaphthalein NSC 354317 angiotensin converting enzyme 2 ACE2 hypertension blood pressure activators fibrosis
10010662 Rilmenidine-d4 85047-14-9 ≥99% deuterated product 2009-04-17 0E-12 rilmenidine-d4 adrenergic agonist agents antihypertensive deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry
10010586 Sildenafil-d8 Citrate - >98% deuterated product 2008-04-14 11.933701657459 sildenafil-d8-citrate SPI PAH drugs males pulmonary inpotance ER erectile dysfunction arterial hypertension
10008609 S-NEPC Exclusive - >98% ✓ 2007-05-01 23.396330570901 s-nepc Cytochrome P450 CYP450 subtrates glutathione s-transferase hydrolases procine liver carboxylesterase hydrolysis spectrophotometry (+)-NEPC (-)-NEPC hypertension sEH epoxides sEH inhibitor substrate GST endocrinology
600090 Soluble Epoxide Hydrolase Cell-Based Assay Kit - 2009-05-14 58.766314127860 soluble-epoxide-hydrolase-cell-based-assay-kit sEH Cell-Based Assay Kit kits assays measuring measurement mammalian epoxides α/β-hydrolases enzymes catalyzes hydrolysis exogenous endogenous vicinal diols homodimers C-terminal N-terminal domains vasodilatory vasodilation anti-inflammatory hypertension vascular inflammation inhibitors therapeutics fluorescence-based fluorescent whole cells Epoxy Fluor 7 6-methoxy-2-naphthaldehyde AUDA
10011669 Soluble Epoxide Hydrolase (human recombinant) - ≥95% 2008-07-02 312.558116022099 soluble-epoxide-hydrolase-human-recombinant CEH; Cytosolic Epoxide Hydrolase; sEH; Epoxide Hydrolase 2; EPHX2 recombinant proteins mammalian hydrolases enzymes exogenous endogenous his-tags hexahistindes His-tagged anti-inflammatory inflammation sehs hydrolases hydrolysis
10011671 Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit - 2009-02-24 73.638447513812 soluble-epoxide-hydrolase-inhibitor-screening-assay-kit sEH Inhibitor Screening Assay Kit epoxides hydrolases sEHs inhibits inhibition assays kits fluorescence-based catalyzes hydrolysis exogenous endogenous vicinal diols substrates EETs epoxyeicosatrienoic acids vasodilatory vasodilation anti-inflammatory molecules therapy therapeutics hypertension vascular diseases PHOME (3-phenyl-oxiranyl)-acetic acid cyano-(6-methoxy-naphthalen-2-yl)-methyl ester 6-methoxy-2-naphthaldehyde excitation emission wavelengths a/b-hydrolases alpha/beta-hydrolases .alpha./.beta.-hydrolases enzymes homodimers C-terminal C-terminus animals models cyanohydrins cyanide ions
10011670 Soluble Epoxide Hydrolase (murine recombinant from Sf21 cells) Exclusive - ≥95% ✓ 2008-07-01 44.923475138121 soluble-epoxide-hydrolase-murine-recombinant-from-sf21-cells sEH; Epoxide Hydrolase 2; EPHX2; Cytosolic Epoxide Hydrolase; CEH recombinant proteins mammalian hydrolases enzymes exogenous endogenous hexahistidine His-tag His-tagged N-terminal anti-inflammatory inflammation 10278
10010146 Soluble Epoxide Hydrolase Polyclonal Antibody - 2008-03-03 15.367648480662 soluble-epoxide-hydrolase-polyclonal-antibody Epoxide Hydrolase 2; EPHX2; sEH; Cytosolic Epoxide Hydrolase (CEH) metabolism hypertension inflammation EpETrEs EETs DiHETrEs DHET inhibitors inhibit inhibitions epoxyeicosatrienoic acids eicosatrienoic WB western blots blotting immunoblotting
10162 Treprostinil 81846-19-7 >98% 2005-08-30 107.833449969306 treprostinil primary pulmonary hypertension PPH arterial vascular resistance stable analogs prostacyclins increase plasma half-life vasodilatory inhibits inflammatory cytokines inhibition inhibitors GM-CF human alveolar macrophages NF-KB NF-.kappa. translocations nucleus NF-kappaB nfkb nf-kb NF-.kappa.B atherosclerosis
700320 Uric Acid Assay Kit New - 2010-08-30 0E-12 uric-acid-assay-kit Urate Assay Kit kits assays measures measurement acids human purines metabolisms urine serum renal excretion excreted allantoin enzymes urate oxidases uricase genes obesity alcohol consumption hyperuricemia gout kidney stones metabolic syndromes hypertension cardiovascular diseases exercise-induced acute failure hypouricemia
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article and Newsletter Archives Analysis Tools Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2010 Cayman Chemical Company